Belmont, CA, United States of America

Martin Pieprzyk

USPTO Granted Patents = 13 


Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 412(Granted Patents)


Location History:

  • San Francisco, CA (US) (2014)
  • Menlo Park, CA (US) (2011 - 2016)
  • Belmont, CA (US) (2010 - 2018)

Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Innovator Spotlight: Martin Pieprzyk - Revolutionizing Single-cell Analysis in Belmont, CA

Introduction:

Martin Pieprzyk, an esteemed inventor based in Belmont, California, has made significant strides in the field of single-cell nucleic acid analysis. With an impressive portfolio of 13 patents to his name, Pieprzyk's innovative solutions are transforming the landscape of genomic research.

Latest Patents:

Pieprzyk's latest patents showcase his groundbreaking work in single-cell nucleic acid analysis. His invention focuses on methods for analyzing genomic DNA and RNA from small samples or even individual cells. By utilizing techniques such as whole genome amplification, preamplification, and amplification of target nucleic acids, Pieprzyk's methods offer unprecedented insights at a cellular level. Additionally, his integrated chip carriers with thermocycler interfaces provide efficient and precise temperature control for reactions in separate chambers, enhancing the accuracy and reliability of experimental results.

Career Highlights:

Currently affiliated with Fluidigm Corporation, Pieprzyk continues to push the boundaries of scientific discovery in the field of genomics. His contributions have not only garnered acclaim within the research community but have also established him as a leading figure in the development of cutting-edge technologies for molecular analysis.

Collaborations:

Pieprzyk's collaborative efforts with esteemed colleagues such as Robert Grossman and Marc Alexander Unger have further enriched his innovative projects. Together, they have synergized their expertise to drive advancements in single-cell analysis, paving the way for new possibilities in genomic research.

Conclusion:

In conclusion, Martin Pieprzyk's dedication to pioneering novel methods for single-cell nucleic acid analysis underscores his commitment to driving scientific progress. His inventive spirit and collaborative approach signify a bright future for the field of genomics, with potential implications for diverse applications in research and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…